Navigation Links
Cell Line Nucleofector Kit V from Lonza Cologne AG

ProductsCell Line Nucleofector Kit V from Lonza Cologne AG
Company Lonza Cologne AG
Item Cell Line Nucleofector Kit V
Price 
Description For nucleofection of optimized cell lines in combination with the corresponding optimized protocol including the nucleofection parameters. Nucleofector Kits are only functional in combination with the Nucleofector Device.

Different cell lines can be transfected with this kit. The corresponding efficiencies and viabilities are given in brackets in percent (Efficiency [%] / viability [%]).

Cell Lines:
3T3-L1 pre-ad (73/59)
293 (ATCC) (84/---)
293 (DSMZ) (57/---)
32D (ATCC) (79/61)
A20 (ATCC) (74/81)
AGS (ATCC) (73/62)
ARPE-19 (ATCC) (83/92)
BA/F3 (DSMZ) (88/80)
C2C12 (ATCC) (82/67)
C6 (ATCC) (87/80)
COS-1 (ATCC) (49/64)
COS-7 (DSMZ) (85/---)
HaCaT (DKFZ) (43/---)
HCT116 (ATCC) (78/50)
HepG2 (64/---)
HL-60 (ATCC) (50/---)
Jurkat (ATCC) (54/---)
Jurkat (DSMZ) (68/---)
K562 (ATCC) (89/---)
K562 (DSMZ) (79/---)
MCF-7 (ATCC) (71/---)
MDA-MB231 (ATCC) (80/77)
MDA-MB468 (ATCC) (60/94)
NCTC clone 929 (ATCC) (67/91)
Neuro-2a (ATCC) (76/79)
P19 (ATCC) (85/80)
PC12 (34/---)
PC-3 (ATCC) (81/60)
Raji (ATCC) (58/67)
Ramos (ATCC) (27/72)
RAW 264.7 (65/74)
RBL-1 (ATCC) (84/67)
Saos-2 (ATCC) (82/79)
SH-SY5Y (ATCC) (82/60)
SK-N-SH (ATCC) (85/73)
SK-OV-3 (ATCC) (89/60)
sus.CHO (ECACC) (92/80)
SW480 (ATCC) (60/86)
T-47D (ATCC) (51/94)
THP-1 (ATCC) (67/60)
U-2 OS (ATCC) (98/88)
U937 (ATCC) (56/50)
Vero (ATCC) (79/97)

If your cell line is not listed, please consult our cell database at the link below.

Info Lonza Cologne AG

Nattermannallee 1
50829 Koeln
Germany

Customer Service: 49 (0)221-99199-0
Fax Number: 49 (0)221-99199-111
Web Site: http://www.lonza.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. Cell Line Nucleofector Kit T from Lonza Cologne AG
... reagent has been developed for use ... reduction of nonspecific background staining due ... describe blocking peroxidase with hydrogen peroxide. ... in combination with additional novel components ...
Phospho-Btk (Tyr223) Antibody...
Rad51B...
p27 rabbit polyclonal antibody...
Biology Products:
(Date:6/7/2016)... , June 7, 2016  Syngrafii Inc. ... a business relationship that includes integrating Syngrafii,s patented ... branch project. This collaboration will result in greater ... the credit union, while maintaining existing document workflow ... http://photos.prnewswire.com/prnh/20160606/375871LOGO ...
(Date:6/2/2016)... LONDON , June 2, 2016 ... has awarded the 44 million US Dollar project, ... Security Embossed Vehicle Plates including Personalization, Enrolment, and IT Infrastructure ... world leader in the production and implementation of Identity Management ... in January, however Decatur was selected ...
(Date:6/2/2016)... Perimeter Surveillance & Detection Systems, Biometrics & ... & Other Service  The latest report from ... of the global Border Security market . Visiongain ... billion in 2016. Now: In November 2015 ... and hardware technologies for advanced video surveillance. ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of ... the Cary 5000 and the 6000i models are higher end machines that use the ... of the spectrophotometer’s light beam from the bottom of the cuvette holder. , ...
(Date:6/23/2016)... June 23, 2016 /PRNewswire/ - FACIT has announced ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" ... commercialization of a portfolio of first-in-class WDR5 inhibitors ... such as WDR5 represent an exciting class of ... precision medicine for cancer patients. Substantial advances have ...
(Date:6/23/2016)... June, 23, 2016  The Biodesign Challenge (BDC), a ... ways to harness living systems and biotechnology, announced its ... in New York City . ... students, showcased projects at MoMA,s Celeste Bartos Theater during ... , MoMA,s senior curator of architecture and design, and ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology: